Literature DB >> 1233267

Disposition of quercetin in man after single oral and intravenous doses.

R Gugler, M Leschik, H J Dengler.   

Abstract

The pharmacokinetics of quercetin, a flavonoid, have been studied in 6 volunteers after single intravenous (100 mg) and oral (4 g) doses. The data after iv administration were analyzed according to a two compartment open model with half lives of 8.8 +/- 1.2 min for the alpha phase and 2.4 +/- 0.2 h for the beta phase (predominant half life), respectively. Protein binding was greater than 98%. The apparent volume of distribution was small at 0.34 +/- 0.03 1/kg. Of the intravenous dose 7.4 +/- 1.2% was excreted in urine as a conjugated metabolite, and 0.65 +/- 0.1% was excreted unchanged. After oral administration no measurable plasma concentrations could be detected, nor was any quercetin found in urine, either unchanged or in a metabolized form. These results exclude absorption of more than 1% of unchanged drug. Recovery in faeces after the oral dose was 53 +/- 5%, which suggests extensive degradation by microorganisms in the gut. The data obtained show that oral administration of flavonoids may be of questionable value.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1233267     DOI: 10.1007/bf00614022

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

1.  The metabolic fate of rutin and quercetin in the animal body.

Authors:  A N BOOTH; F DEEDS; F T JONES; C W MURRAY
Journal:  J Biol Chem       Date:  1956-11       Impact factor: 5.157

2.  Determination of added rutin in urine.

Authors:  W L PORTER; D F DICKEL; J F COUCH
Journal:  Arch Biochem       Date:  1949-04

3.  Sensitive fluorometric method for determination of quercetin in plasma or urine.

Authors:  R Gugler; H J Dengler
Journal:  Clin Chem       Date:  1973-01       Impact factor: 8.327

4.  Studies on flavonoid metabolism. Absorption and metabolism of (+)-catechin in man.

Authors:  N P Das
Journal:  Biochem Pharmacol       Date:  1971-12       Impact factor: 5.858

5.  The biliary excretion of hydroxyethylrutosides and other flavonoids in the rat.

Authors:  A Barrow; L A Griffiths
Journal:  Biochem J       Date:  1971-11       Impact factor: 3.857

6.  [Quantitative determination of protein binding of drugs by gel filtration].

Authors:  J Krieglstein; G Kuschinsky
Journal:  Arzneimittelforschung       Date:  1968-03

7.  Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors:  S Riegelman; J C Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

8.  Identification of flavanone metabolites in rat urine by combined gas-liquid chromatography and mass spectrometry.

Authors:  N P Das; K N Scott; J H Duncan
Journal:  Biochem J       Date:  1973-12       Impact factor: 3.857

9.  Studies on flavonoid metabolism. Biliary and urinary excretion of metabolites of (+)-(U- 14 C)catechin.

Authors:  N P Das; S P Sothy
Journal:  Biochem J       Date:  1971-11       Impact factor: 3.857

10.  Studies on flavonoid metabolism. Metabolism of (+)-[14C] catechin in the rat and guinea pig.

Authors:  N P Das; L A Griffiths
Journal:  Biochem J       Date:  1969-12       Impact factor: 3.857

View more
  49 in total

1.  Anti-inflammatory Effect and Toxicology Analysis of Oral Delivery Quercetin Nanosized Emulsion in Rats.

Authors:  Gabriela Hädrich; Gustavo Richter Vaz; Michelle Maidana; Jadel Muller Kratz; Gecioni Loch-Neckel; Daniely Cornélio Favarin; Alexandre de Paula Rogerio; Flávio Manoel Rodrigues da Silva; Ana Luiza Muccillo-Baisch; Cristiana Lima Dora
Journal:  Pharm Res       Date:  2015-12-18       Impact factor: 4.200

2.  Cancer chemopreventive properties of orally bioavailable flavonoids--methylated versus unmethylated flavones.

Authors:  Thomas Walle; Nga Ta; Toshihiko Kawamori; Xia Wen; Petra A Tsuji; U Kristina Walle
Journal:  Biochem Pharmacol       Date:  2006-12-28       Impact factor: 5.858

3.  Protective action of hydroxyethyl rutosides on singlet oxygen challenged cardiomyocytes.

Authors:  H G Olbrich; P Grabisch; A Grossmann; T Rinne; H Klepzig; E Mutschler
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

Review 4.  The nutritional incidence of flavonoids: some physiological and metabolic considerations.

Authors:  C R Roger
Journal:  Experientia       Date:  1988-09-15

5.  Pharmacokinetic data. Pharmacokinetic parameters estimated from intravenous data by uniform methods and some of their uses.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1977-04

Review 6.  The analgesic potential of glycosides derived from medicinal plants.

Authors:  Haroon Khan; Aini Pervaiz; Sebastiano Intagliata; Niranjan Das; Kalyan C Nagulapalli Venkata; Atanas G Atanasov; Agnieszka Najda; Seyed Mohammad Nabavi; Dongdong Wang; Valeria Pittalà; Anupam Bishayee
Journal:  Daru       Date:  2020-02-14       Impact factor: 3.117

7.  Anti-allergic effects of enzymatically modified isoquercitrin (α-oligoglucosyl quercetin 3-O-glucoside), quercetin 3-O-glucoside, α-oligoglucosyl rutin, and quercetin, when administered orally to mice.

Authors:  Toshiaki Makino; Misaki Kanemaru; Shuji Okuyama; Ryosuke Shimizu; Hisashi Tanaka; Hajime Mizukami
Journal:  J Nat Med       Date:  2013-03-14       Impact factor: 2.343

8.  Inhibitory effect of flavonoids on the efflux of N-acetyl 5-aminosalicylic acid intracellularly formed in Caco-2 cells.

Authors:  Shin Yoshimura; Kentaro Kawano; Ryusuke Matsumura; Narumi Sugihara; Koji Furuno
Journal:  J Biomed Biotechnol       Date:  2009-08-13

Review 9.  Methylation of dietary flavones increases their metabolic stability and chemopreventive effects.

Authors:  Thomas Walle
Journal:  Int J Mol Sci       Date:  2009-11-18       Impact factor: 6.208

10.  Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity.

Authors:  D J L Jones; J H Lamb; R D Verschoyle; L M Howells; M Butterworth; C K Lim; D Ferry; P B Farmer; A J Gescher
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.